230 related articles for article (PubMed ID: 18516969)
1. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method].
Naraoka H; Suzumura K; Takeuchi K; Sasayama T
Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969
[TBL] [Abstract][Full Text] [Related]
2. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
3. Molecular approaches to the identification of biomarkers of exposure and effect--report of an expert meeting organized by COST Action B15. November 28, 2003.
Gundert-Remy U; Dahl SG; Boobis A; Kremers P; Kopp-Schneider A; Oberemm A; Renwick A; Pelkonen O
Toxicol Lett; 2005 Apr; 156(2):227-40. PubMed ID: 15737486
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in metabonomics].
Xu GW; Lu X; Yang SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):701-11. PubMed ID: 18595244
[TBL] [Abstract][Full Text] [Related]
5. Metabonomics: a useful tool for the future surgeon.
Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
[TBL] [Abstract][Full Text] [Related]
6. Metabonomic modeling of drug toxicity.
Keun HC
Pharmacol Ther; 2006 Jan; 109(1-2):92-106. PubMed ID: 16051371
[TBL] [Abstract][Full Text] [Related]
7. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology.
Coen M; Holmes E; Lindon JC; Nicholson JK
Chem Res Toxicol; 2008 Jan; 21(1):9-27. PubMed ID: 18171018
[TBL] [Abstract][Full Text] [Related]
8. Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information.
Chen J; Zhao X; Fritsche J; Yin P; Schmitt-Kopplin P; Wang W; Lu X; Häring HU; Schleicher ED; Lehmann R; Xu G
Anal Chem; 2008 Feb; 80(4):1280-9. PubMed ID: 18193893
[TBL] [Abstract][Full Text] [Related]
9. The Biomarkers Consortium: on the critical path of drug discovery.
Altar CA
Clin Pharmacol Ther; 2008 Feb; 83(2):361-4. PubMed ID: 18183037
[TBL] [Abstract][Full Text] [Related]
10. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
[TBL] [Abstract][Full Text] [Related]
11. [Metabonomics in medical and pharmaceutical research].
Liu CX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):712-8. PubMed ID: 18595245
[TBL] [Abstract][Full Text] [Related]
12. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease.
Puntmann VO
Postgrad Med J; 2009 Oct; 85(1008):538-45. PubMed ID: 19789193
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers: a valuable tool in clinical research and medical practice.
Carini C
IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
[TBL] [Abstract][Full Text] [Related]
14. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
15. Multi-species toxicology approaches for oncology drugs: the US perspective.
Tomaszewski JE
Eur J Cancer; 2004 Apr; 40(6):907-13. PubMed ID: 15120046
[TBL] [Abstract][Full Text] [Related]
16. Toxicogenomics in biomarker discovery.
Decristofaro MF; Daniels KK
Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging to biomarker development in neuroscience.
Frost JJ
Ann N Y Acad Sci; 2008 Nov; 1144():251-5. PubMed ID: 19076382
[TBL] [Abstract][Full Text] [Related]
18. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis.
Lee JW; Hall M
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1259-71. PubMed ID: 19038585
[TBL] [Abstract][Full Text] [Related]
19. The 2nd annual oncology biomarkers conference.
Schiffer E
Biomark Med; 2009 Apr; 3(2):203-9. PubMed ID: 20477511
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
